← Evidence map

ArticleTherapeutic advances in medical oncology2024

Improving olaparib exposure to optimize adverse effects management.

Marylise Sterlé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38665845